tiprankstipranks
Advertisement
Advertisement

AMRX Stock Latest News

5 Reasons to Be Bullish on Stocks
Market News5 Reasons to Be Bullish on Stocks
2d ago
AMRX
AVAH
Amneal Pharmaceuticals announces interim results from ELEVATE-PD study
PremiumThe Fly
Amneal Pharmaceuticals announces interim results from ELEVATE-PD study
7d ago
AMRX
Amneal Pharmaceuticals announces FDA approval of romidepsin injection solution
PremiumThe Fly
Amneal Pharmaceuticals announces FDA approval of romidepsin injection solution
8d ago
AMRX
Amneal Pharmaceuticals announces FDA approval of romidepsin injection solution
PremiumThe Fly
Amneal Pharmaceuticals announces FDA approval of romidepsin injection solution
8d ago
AMRX
Amneal Pharmaceuticals price target raised to $16 from $15 at Barclays
PremiumThe Fly
Amneal Pharmaceuticals price target raised to $16 from $15 at Barclays
23d ago
AMRX
Amneal Pharma Bets Big on Biosimilars in Q1 Call
PremiumCompany AnnouncementsAmneal Pharma Bets Big on Biosimilars in Q1 Call
23d ago
AMRX
Amneal Shareholders Back Board, Pay and Auditor at Meeting
Premium
Company Announcements
Amneal Shareholders Back Board, Pay and Auditor at Meeting
1M ago
8K
AMRX
Amneal Pharmaceuticals reports Q1 EPS 27c, consensus 17c
Premium
The Fly
Amneal Pharmaceuticals reports Q1 EPS 27c, consensus 17c
1M ago
AMRX
Amneal Pharmaceuticals backs FY26 adjusted EPS view 95c-$1.05, consensus $1.00
PremiumThe Fly
Amneal Pharmaceuticals backs FY26 adjusted EPS view 95c-$1.05, consensus $1.00
1M ago
AMRX
Amneal Pharma Bets Big On Biosimilars Growth
PremiumCompany Announcements
Amneal Pharma Bets Big On Biosimilars Growth
1M ago
AMRX
Is AMRX a Buy, Before Earnings?
PremiumPre-Earnings
Is AMRX a Buy, Before Earnings?
1M ago
AMRX
Amneal to Acquire Kashiv, Expanding Biosimilars Platform
PremiumCompany Announcements
Amneal to Acquire Kashiv, Expanding Biosimilars Platform
2M ago
8K
AMRX
Amneal Pharmaceuticals raises FY26 adjusted EPS view to 95c-$1.05 from 93c-$1.03
PremiumThe FlyAmneal Pharmaceuticals raises FY26 adjusted EPS view to 95c-$1.05 from 93c-$1.03
2M ago
AMRX
Amneal Pharmaceuticals to acquire Kashiv BioSciences
Premium
The Fly
Amneal Pharmaceuticals to acquire Kashiv BioSciences
2M ago
AMRX
Amneal Pharmaceuticals reports Q1 adjusted EPS 27c, consensus 17c
Premium
The Fly
Amneal Pharmaceuticals reports Q1 adjusted EPS 27c, consensus 17c
2M ago
AMRX
Amneal announces additional interim Phase 4 ELEVATE-PD study results
PremiumThe Fly
Amneal announces additional interim Phase 4 ELEVATE-PD study results
2M ago
AMRX
Amneal Pharmaceuticals initiated with a Buy at UBS
PremiumThe Fly
Amneal Pharmaceuticals initiated with a Buy at UBS
2M ago
AMRX
Amneal announces U.S. launch of two respiratory metered-dose inhalation products
PremiumThe Fly
Amneal announces U.S. launch of two respiratory metered-dose inhalation products
2M ago
AMRX
Amneal Pharmaceuticals Earnings Call: Growth Amid Transition
PremiumCompany Announcements
Amneal Pharmaceuticals Earnings Call: Growth Amid Transition
3M ago
AMRX
Amneal Pharmaceuticals price target raised to $17 from $15 at Goldman Sachs
PremiumThe FlyAmneal Pharmaceuticals price target raised to $17 from $15 at Goldman Sachs
3M ago
AMRX
Amneal Pharmaceuticals price target raised to $17 from $15 at Truist
Premium
The Fly
Amneal Pharmaceuticals price target raised to $17 from $15 at Truist
3M ago
AMRX
Truist ups Amneal Pharmaceuticals price target, says pullback great entry point
Premium
The Fly
Truist ups Amneal Pharmaceuticals price target, says pullback great entry point
3M ago
AMRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >